Go Pro

Ventas (VTR) Stock Forecast & Price Target

Ventas logo
$90.27 -1.84 (-2.00%)
As of 03:58 PM Eastern

Ventas - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
3
Buy
14

Based on 17 Wall Street analysts who have issued ratings for Ventas in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 3 have given a hold rating, and 14 have given a buy rating for VTR.

Consensus Price Target

$99.00
9.67% Upside
According to the 17 analysts' twelve-month price targets for Ventas, the average price target is $99.00. The highest price target for VTR is $110.00, while the lowest price target for VTR is $88.00. The average price target represents a forecasted upside of 9.67% from the current price of $90.27.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for VTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ventas and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VTR Analyst Ratings Over Time

TypeCurrent Forecast
9/4/25 to 9/4/26
1 Month Ago
8/5/25 to 8/5/26
3 Months Ago
6/6/25 to 6/6/26
1 Year Ago
9/4/24 to 9/4/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
15 Buy rating(s)
14 Buy rating(s)
9 Buy rating(s)
Hold
3 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$99.00$97.56$95.19$74.36
Forecasted Upside9.67% Upside5.42% Upside15.90% Upside9.86% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

VTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ventas Stock vs. The Competition

TypeVentasReal Estate CompaniesBroader Market
Consensus Rating Score
2.82
2.32
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside9.45% Upside38.35% Upside13.99% Upside
News Sentiment Rating
Positive News

See Recent VTR News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/2/2026
Scotiabank logo
Scotiabank
4 of 5 stars
Nicholas Yulico
Nicholas Yulico
3 of 5 stars
Boost TargetSector Perform$93.00 ➝ $95.00+3.14%
9/1/2026
John Kilichowski
John Kilichowski
3 of 5 stars
Boost TargetOverweight$96.00 ➝ $104.00+14.06%
8/31/2026
Barclays PLC logo
Barclays
3 of 5 stars
Richard Hightower
Richard Hightower
3 of 5 stars
Boost TargetEqual Weight$99.00 ➝ $102.00+11.14%
8/14/2026Boost TargetOutperform$98.00 ➝ $99.00+8.56%
8/11/2026Boost TargetOutperform$105.00 ➝ $107.00+16.42%
8/4/2026Boost TargetBuy$100.00 ➝ $110.00+20.94%
7/31/2026Boost TargetOverweight$97.00 ➝ $102.00+11.91%
7/22/2026Boost TargetOutperform$98.00 ➝ $104.00+7.10%
7/21/2026 UpgradeHold (C+)Buy (B-)
6/16/2026Initiated CoverageOutperform$94.00+12.11%
6/16/2026 Reiterated RatingBuy$100.00+19.88%
5/19/2026 Reiterated RatingBuy$110.00+24.82%
5/12/2026Boost TargetBuy$97.00 ➝ $100.00+12.85%
5/11/2026Boost TargetOverweight$93.00 ➝ $94.00+7.60%
5/7/2026Boost TargetOverweight$90.00 ➝ $95.00+11.10%
5/4/2026Boost TargetNeutral$85.00 ➝ $93.00+5.55%
4/29/2026 Reiterated RatingOutperform$95.00+8.90%
2/13/2026Set Target$90.00+5.70%
2/10/2026Set Target$88.00+5.52%
2/14/2025Boost TargetOutperform$69.00 ➝ $78.00+18.10%
1/17/2025UpgradeNeutralOutperform$66.00 ➝ $65.00+11.31%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:09 PM ET.


Should I Buy Ventas Stock? VTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 1, 2026. Please send any questions or comments about these Ventas pros and cons to contact@marketbeat.com.

Ventas
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Ventas, Inc.:

  • Ventas, Inc. recently reported strong financial performance for the quarter ended July 29, 2026, with revenue of $1.73 billion, which exceeded analyst estimates of $1.68 billion and represented a 21.7% increase compared to the same period last year. This significant year-over-year growth indicates robust demand for the company's healthcare real estate assets, such as senior housing communities and medical office buildings, suggesting a solid fundamental foundation for future earnings potential.
  • The stock currently trades at $92.03, which is below the consensus price target of $98.17 set by fourteen equities research analysts who have rated the stock with a Buy rating. This discrepancy between the current market price and the average analyst target suggests that the stock may be undervalued relative to its expected future performance, offering potential upside for investors who align with the "Moderate Buy" consensus rating.
  • Recent institutional activity shows significant new capital entering the company, with BlackRock Inc. establishing a new position valued at approximately $4.95 billion during the second quarter. Additionally, UBS AM increased its holdings by 5.5% and the Public Employees Retirement System of Ohio acquired a new stake worth $61.49 million. This influx of large-scale institutional investment often signals confidence in the company's long-term stability and growth prospects among sophisticated market participants.
  • Ventas, Inc. offers a dividend yield of 2.27%, providing a steady income stream for investors. As a real estate investment trust (REIT) specializing in healthcare-related properties, the company benefits from the demographic tailwind of an aging population, which supports consistent occupancy rates and rental income. This combination of income generation and structural demand makes it an attractive option for investors seeking both yield and capital appreciation in the healthcare sector.
  • The company has demonstrated operational efficiency and market leadership, as evidenced by its status as a leading S&P 500 real estate investment trust with a portfolio of approximately 1,400 properties. The recent beat on earnings per share, where Ventas reported $0.97 compared to the consensus estimate of $0.96, further underscores the management team's ability to deliver results that meet or exceed expectations, reinforcing investor confidence in the company's execution capabilities.

Ventas
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Ventas, Inc. for these reasons:

  • The company's valuation appears stretched, with a price-to-earnings ratio of 170.43, which is significantly higher than typical market averages. This high multiple suggests that the stock price is pricing in substantial future growth that may not materialize, leaving little room for error if earnings growth slows. Investors should be cautious about entering at these levels, as the high P/E ratio indicates that the stock is expensive relative to its current earnings power.
  • Short interest in Ventas, Inc. has been rising, with 23,700,623 shares shorted as of the most recent record date, representing 4.65% of the float. This increase in short selling activity suggests that a portion of the market is betting against the stock's future performance, potentially due to concerns about valuation or sector-specific risks. A high short interest can also lead to increased volatility and potential for sharp price declines if the stock faces negative news.
  • Recent insider activity has been predominantly negative, with multiple executives, including CEO Debra A. Cafaro and CFO Robert F. Probst, selling significant numbers of shares in early 2026. For instance, the CEO sold 10,322 shares at an average price of $77.66 in February 2026, and the CFO sold 29,930 shares at $77.25 in January 2026. While insider sales can be part of routine financial planning, a pattern of selling by key management figures may signal a lack of confidence in the stock's near-term upside or a desire to diversify personal holdings.
  • The company's balance sheet shows a debt-to-equity ratio of 0.86, which, while manageable, indicates a significant level of leverage. In a rising interest rate environment, higher debt levels can increase financing costs and reduce profitability. Additionally, the current ratio of 0.44 suggests that the company's current liabilities exceed its current assets, which could pose liquidity challenges if the company faces unexpected expenses or if credit markets tighten.
  • Ventas, Inc. is exposed to sector-specific risks associated with the healthcare real estate market, including regulatory changes, labor shortages, and potential shifts in healthcare delivery models. The company's reliance on long-term leases with healthcare providers means that any downturn in the healthcare sector or changes in government funding for senior housing and skilled nursing facilities could directly impact its revenue and occupancy rates. Investors should be aware of these external factors that could negatively affect the company's performance.

VTR Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Ventas is $99.00, with a high forecast of $110.00 and a low forecast of $88.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ventas in the last twelve months. There are currently 3 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" VTR shares.

According to analysts, Ventas's stock has a predicted upside of 9.67% based on their 12-month stock forecasts.

Over the previous 90 days, Ventas's stock had 2 upgrades and 1 downgrade by analysts.

Analysts like Ventas more than other "real estate" companies. The consensus rating for Ventas is Moderate Buy while the average consensus rating for "real estate" companies is Hold. Learn more on how VTR compares to other companies.


MarketBeat monitors more than a dozen sources for Ventas analyst ratings, with the most recent rating issued on 9/2/2026.
From Our Partners